Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $1.59 billion. The enterprise value is $1.12 billion.

Market Cap	1.59B
Enterprise Value	1.12B

Important Dates

The next confirmed earnings date is Monday, May 4, 2026, after market close.

Earnings Date	May 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Nuvation Bio has 347.69 million shares outstanding. The number of shares has increased by 27.08% in one year.

Current Share Class	346.69M
Shares Outstanding	347.69M
Shares Change (YoY)	+27.08%
Shares Change (QoQ)	+0.57%
Owned by Insiders (%)	24.34%
Owned by Institutions (%)	53.05%
Float	237.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.21
Forward PS	8.33
PB Ratio	5.17
P/TBV Ratio	5.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	17.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.22.

Current Ratio	6.95
Quick Ratio	6.67
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.57

Financial Efficiency

Return on equity (ROE) is -53.18% and return on invested capital (ROIC) is -31.50%.

Return on Equity (ROE)	-53.18%
Return on Assets (ROA)	-23.46%
Return on Invested Capital (ROIC)	-31.50%
Return on Capital Employed (ROCE)	-41.57%
Weighted Average Cost of Capital (WACC)	13.23%
Revenue Per Employee	$211,081
Profits Per Employee	-$686,668
Employee Count	298
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +114.09% in the last 52 weeks. The beta is 1.61, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	+114.09%
50-Day Moving Average	4.80
200-Day Moving Average	4.92
Relative Strength Index (RSI)	42.50
Average Volume (20 Days)	3,259,637

Short Selling Information

The latest short interest is 50.30 million, so 14.47% of the outstanding shares have been sold short.

Short Interest	50.30M
Short Previous Month	49.45M
Short % of Shares Out	14.47%
Short % of Float	21.21%
Short Ratio (days to cover)	15.77

Income Statement

In the last 12 months, Nuvation Bio had revenue of $62.90 million and -$204.63 million in losses. Loss per share was -$0.60.

Revenue	62.90M
Gross Profit	53.60M
Operating Income	-213.06M
Pretax Income	-204.63M
Net Income	-204.63M
EBITDA	-211.33M
EBIT	-213.06M
Loss Per Share	-$0.60

Full Income Statement

Balance Sheet

The company has $529.21 million in cash and $66.94 million in debt, giving a net cash position of $462.27 million or $1.33 per share.

Cash & Cash Equivalents	529.21M
Total Debt	66.94M
Net Cash	462.27M
Net Cash Per Share	$1.33
Equity (Book Value)	305.72M
Book Value Per Share	0.88
Working Capital	489.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$173.43 million and capital expenditures -$354,000, giving a free cash flow of -$173.78 million.

Operating Cash Flow	-173.43M
Capital Expenditures	-354,000
Depreciation & Amortization	1.74M
Net Borrowing	197.71M
Free Cash Flow	-173.78M
FCF Per Share	-$0.50

Full Cash Flow Statement

Margins

Gross Margin	85.22%
Operating Margin	-338.72%
Pretax Margin	-325.31%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.08%
Shareholder Yield	-27.08%
Earnings Yield	-12.91%
FCF Yield	-10.96%

Analyst Forecast

The average price target for Nuvation Bio is $11.38, which is 149.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.38
Price Target Difference	149.56%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	51.42%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nuvation Bio has an Altman Z-Score of -0.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.35
Piotroski F-Score	3